MARKET

CRSP

CRSP

Crispr Therapeut
NASDAQ
52.42
-2.66
-4.83%
Pre Market: 52.69 +0.27 +0.52% 08:34 05/08 EDT
OPEN
54.53
PREV CLOSE
55.08
HIGH
55.47
LOW
51.71
VOLUME
5.23K
TURNOVER
271.37M
52 WEEK HIGH
78.48
52 WEEK LOW
33.03
MARKET CAP
5.06B
P/E (TTM)
-8.4400
1D
5D
1M
3M
1Y
5Y
1D
Crispr Therapeutics Is Maintained at Buy by Citigroup
Dow Jones · 1d ago
Crispr Therapeutics Price Target Raised to $82.00/Share From $80.00 by Citigroup
Dow Jones · 1d ago
Citigroup Maintains Buy on CRISPR Therapeutics, Raises Price Target to $82
Benzinga · 1d ago
Crispr Therapeutics Q1 Earnings: Casgevy Growth, H2 In-Vivo Catalysts Make Buy Case
Seeking Alpha · 2d ago
Stock Picks From Seeking Alpha's April 2026 New Analysts
Seeking Alpha · 2d ago
Analysts Conflicted on These Healthcare Names: Dexcom (DXCM), Ironwood Pharma (IRWD) and Crispr Therapeutics AG (CRSP)
TipRanks · 2d ago
Crispr Therapeutics price target lowered to $83 from $86 at BofA
TipRanks · 3d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: ADC Therapeutics (ADCT), Crispr Therapeutics AG (CRSP) and BioMarin Pharmaceutical (BMRN)
TipRanks · 3d ago
More
About CRSP
CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.

Webull offers Crispr Therapeutics AG stock information, including NASDAQ: CRSP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRSP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRSP stock methods without spending real money on the virtual paper trading platform.